Prime Medicine Inc (PRME)
7.085
+0.04
(+0.64%)
USD |
NASDAQ |
May 17, 16:00
7.085
0.00 (0.00%)
After-Hours: 20:00
Prime Medicine Price: 7.085 for May 17, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 17, 2024 | 7.05 | 7.18 | 6.87 | 7.08 | 610068.0 |
| May 16, 2024 | 6.90 | 7.15 | 6.60 | 7.04 | 846992.0 |
| May 15, 2024 | 6.91 | 7.13 | 6.62 | 6.76 | 537933.0 |
| May 14, 2024 | 6.71 | 7.17 | 6.55 | 6.66 | 842888.0 |
| May 13, 2024 | 5.88 | 6.83 | 5.88 | 6.42 | 1.409M |
| May 10, 2024 | 5.92 | 6.02 | 5.61 | 5.61 | 402497.0 |
| May 09, 2024 | 5.38 | 5.81 | 5.34 | 5.72 | 635287.0 |
| May 08, 2024 | 5.47 | 5.52 | 5.17 | 5.36 | 644082.0 |
| May 07, 2024 | 5.46 | 5.59 | 5.24 | 5.57 | 665973.0 |
| May 06, 2024 | 5.65 | 5.77 | 5.39 | 5.40 | 1.391M |
| May 03, 2024 | 5.92 | 6.09 | 5.45 | 5.59 | 923387.0 |
| May 02, 2024 | 5.37 | 5.72 | 5.12 | 5.61 | 852030.0 |
| May 01, 2024 | 4.88 | 5.59 | 4.85 | 5.27 | 815155.0 |
| Apr 30, 2024 | 5.00 | 5.11 | 4.630 | 4.92 | 1.203M |
| Apr 29, 2024 | 4.90 | 5.14 | 4.65 | 4.86 | 1.268M |
| Apr 26, 2024 | 4.34 | 4.65 | 4.160 | 4.425 | 641595.0 |
| Apr 25, 2024 | 4.57 | 4.598 | 4.11 | 4.30 | 848913.0 |
| Apr 24, 2024 | 4.79 | 4.932 | 4.685 | 4.70 | 522474.0 |
| Apr 23, 2024 | 4.85 | 5.30 | 4.79 | 4.80 | 850794.0 |
| Apr 22, 2024 | 4.69 | 4.91 | 4.375 | 4.78 | 1.446M |
| Apr 19, 2024 | 4.59 | 4.68 | 4.34 | 4.51 | 929147.0 |
| Apr 18, 2024 | 4.93 | 4.98 | 4.56 | 4.59 | 912926.0 |
| Apr 17, 2024 | 5.32 | 5.32 | 4.92 | 4.93 | 652703.0 |
| Apr 16, 2024 | 5.41 | 5.41 | 5.17 | 5.27 | 531654.0 |
| Apr 15, 2024 | 5.71 | 5.72 | 5.40 | 5.44 | 612575.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.30
Minimum
Apr 25 2024
21.12
Maximum
Nov 01 2022
11.97
Average
12.56
Median
Price Benchmarks
| Pacific Biosciences of California Inc | 2.03 |
| 10x Genomics Inc | 25.00 |
| Recursion Pharmaceuticals Inc | 9.42 |
| Verve Therapeutics Inc | 5.965 |
| Ginkgo Bioworks Holdings Inc | 0.8075 |
Price Related Metrics
| Price to Book Value | 3.486 |
| Earnings Yield | -30.79% |
| Market Cap | 850.42M |